对CHK1抑制剂的专利审查 (2019年至今)
Tao Liu1, Mingbo Su2, Yuxuan Wang3
1Institute of Drug Discovery and Design, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China.
Expert opinion on therapeutic patents
|August 18, 2025
概括
检查点激酶1 (CHK1) 抑制剂对于癌症中DNA损伤反应至关重要. 虽然许多都在临床试验中,但没有一个得到批准,这突显了在癌症治疗中需要新的选择性CHK1抑制剂的需要.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- 检查点酶1 (CHK1) 对DNA损伤反应 (DDR) 至关重要,它调节细胞周期检查点,DNA修复和亡.
- 作为癌症治疗药物,CHK1抑制剂正在被研究,有超过15个临床试验,但没有一个获得市场批准.
研究的目的:
- 对瘤学中CHK1抑制剂进行全面的专利审查.
- 分析CHK1抑制剂的组合产品和结构见解.
- 评估目前CHK1抑制剂开发的现状和未来发展方向.
主要方法:
- 从2019年1月到2024年12月的专利文献审查.
- 在Scopus,Espacenet,Web of Science,WIPO,谷歌专利,Cortellis和USPTO数据库中进行的搜索.
主要成果:
- 在不同发展阶段确定了众多CHK1抑制剂.
- 强调了新型骨和组合疗法的重要性.
- 强调了在合理药物设计和生物标志物识别方面正在进行的研究.
结论:
- 开发具有新型结构的强效,选择性CHK1抑制剂对于癌症治疗至关重要.
- 组合疗法和以生物标志物为指导的策略具有显著的前景.
- 为了有效的癌症治疗,CHK1抑制剂研究的进一步进展至关重要.
关键词:
一个瑞士克朗.这是一种CHK1抑制剂.在DDR中,DDR是指DDR.癌症治疗疗法 癌症治疗组合组合组合的组合组合.patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent预测性的生物标志物相关概念视频
Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
M-Cdk Drives Transition Into Mitosis
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Patch Clamp
Many fundamental cell functions such as muscle contraction and nerve transmission rely on the electrical signals produced by the movement of positively and negatively charged ions across the cell membrane. One competent method to record current flowing across the whole cell or single ion channel is the patch-clamp technique.
In this method, a glass micropipette containing electrolyte solution is tightly sealed against a small portion of the cell membrane. As a result, a patch of the cell...
In this method, a glass micropipette containing electrolyte solution is tightly sealed against a small portion of the cell membrane. As a result, a patch of the cell...


